World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Canada
2023

D-Index & Metrics

Microbiology

D-Index
101
Citations
42100
World Ranking
382
National Ranking
26

Medicine

D-Index
115
Citations
57974
World Ranking
4484
National Ranking
169

Harry L.A. Janssen publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Harry L.A. Janssen sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 564 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Harry L.A. Janssen D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Harry L.A. Janssen sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 101 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Microbiology in Canada Leader Award
  • 2022 - Research.com Microbiology in Canada Leader Award

Overview

Harry L.A. Janssen is affiliated with Erasmus University Rotterdam in the Netherlands and has an extensive publication record in the field of medicine, particularly focusing on liver diseases and hepatology. Their research contributions span multiple interconnected domains including epidemiology, hepatology, surgery, immunology, and infectious diseases.

Their primary areas of study include liver disease diagnosis and treatment, hepatitis B virus studies, hepatitis C virus research, liver diseases and immunity, hepatitis viruses studies and epidemiology, liver disease and transplantation, and gallbladder and bile duct disorders.

Frequent venues for Janssen's work consist of several leading journals in gastroenterology and hepatology:

  • Journal of Hepatology
  • The American Journal of Gastroenterology
  • Hepatology
  • Gastroenterology
  • Clinical Gastroenterology and Hepatology

Janssen has collaborated extensively with a number of co-authors, with frequent collaborations noted with:

  • Bettina E. Hansen
  • Jordan J. Feld
  • Milan J. Sonneveld
  • Willem Pieter Brouwer
  • Robert J. de Knegt

Several of Janssen's recent peer-reviewed papers illustrate their focus on liver-related diseases and treatment outcomes:

  • "aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis" (2020), Journal of Hepatology
  • "Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)" (2021), Gastroenterology
  • "Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase" (2020), The American Journal of Gastroenterology
  • "An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B" (2021), Journal of Hepatology
  • "Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity" (2020), Journal of Hepatology

Their research reflects a strong integration of clinical epidemiology and therapeutic strategies aimed at understanding and managing chronic liver diseases, hepatitis B and C infections, and improving survival strategies. The work includes quantitative risk modeling, treatment target identification, and evaluating post-therapy outcomes in diverse patient populations.

Best Publications

  • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

    Pietro Lampertico;Kosh Agarwal;Thomas Berg;Maria Buti

  • Treatment of HCV Infection by Targeting MicroRNA

    Harry L A Janssen;Hendrik W Reesink;Eric J Lawitz;Stefan Zeuzem

  • Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

    Harry L A Janssen;Monika van Zonneveld;Hakan Senturk;Stefan Zeuzem

  • The Rotterdam Study: Objectives and design update

    Albert Hofman;Guy G. O. Brusselle;Sarwa Darwish Murad;Cornelia M. van Duijn

  • Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis

    Bart J Veldt;E Jenny Heathcote;Heiner Wedemeyer;Juerg Reichen

  • Hepatitis B virus infection

    Man-Fung Yuen;Ding-Shinn Chen;Ding-Shinn Chen;Geoffrey M. Dusheiko;Harry L. A. Janssen

  • Budd–Chiari syndrome: a review by an expert panel

    Harry L.A Janssen;Juan-Carlos Garcia-Pagan;Elwyn Elias;Gilles Mentha

  • Etiology, Management, and Outcome of the Budd-Chiari Syndrome

    Sarwa Darwish Murad;Aurelie Plessier;Manuel Hernandez-Guerra;Federica Margherita Fabris

  • Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

    Felix E. De Jongh;Harry L.A. Janssen;Robert A. De Man;Wim C.J. Hop

  • Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

    Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen

  • Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

    George V. Papatheodoridis;Henry Lik Yuen Chan;Bettina E. Hansen;Harry L A Janssen;Harry L A Janssen

  • PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

    George Papatheodoridis;George Dalekos;Vana Sypsa;Cihan Yurdaydin

  • Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b

    Erik H.C.J. Buster;Hajo J. Flink;Yilmaz Cakaloglu;Krzysztof Simon

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

    Unknown

  • Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.

    Erik H.C.J. Buster;Bettina E. Hansen;George K.K. Lau;Teerha Piratvisuth

  • Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

    Monika van Zonneveld;Pieter Honkoop;Bettina E. Hansen;Hubertus G.M. Niesters

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

    Maria Buti;Edward Gane;Wai Kay Seto;Henry L.Y. Chan

  • Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

    M. van Zonneveld;A. B. van Nunen;H. G. M. Niesters;R. A. de Man

  • The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases

    Jean-Jacques Kiladjian;Francisco Cervantes;Franck W. G. Leebeek;Christophe Marzac

  • Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

    Henry Lik-Yuen Chan;Alex Thompson;Michelle Martinot-Peignoux;Teerha Piratvisuth

Frequent Co-Authors

Bettina E. Hansen
Bettina E. Hansen University Health Network
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Solko W. Schalm
Solko W. Schalm Erasmus University Rotterdam
Maria Buti
Maria Buti Instituto de Salud Carlos III
Keith D. Lindor
Keith D. Lindor Arizona State University
Albert Parés
Albert Parés University of Barcelona
Kris V. Kowdley
Kris V. Kowdley Washington State University
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various health and science-related careers, many of which can be pursued through online degrees. For individuals facing unique challenges, including those with past convictions, options like the best associate degrees for felons provide a pathway to re-enter education and build a meaningful career.

Health-focused professions are growing rapidly. For those interested in holistic patient care, pursuing functional medicine NP programs offers specialized knowledge that complements a microbiology background.

Job roles linked to data management and coding are also in high demand. Becoming a certified professional coder can be a lucrative path for those who excel in details and paperwork within health systems.

Another valuable career option is health information management. Earning a health information management degree salary can lead to roles managing medical data, crucial for healthcare efficiency and compliance.

Best Scientists Citing Harry L.A. Janssen

Trending Scientists

Recently Published Articles